Niki BioSolutions, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Niki BioSolutions, Inc. (NIKI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.39 million shares for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-11
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 1.39M shares S-4/A · filed 2026-05-11 | |||
| 2025-09-30 | 1.39M shares 6-K · filed 2026-01-22 | |||
| 2025-06-30 | 1.39M shares 6-K · filed 2025-10-08 | |||
| 2024-12-31 | 1.29M shares S-4/A · filed 2026-05-11 | 1.39M shares 20-F · filed 2025-04-30 | ||
| 2024-06-30 | 1.43M shares 6-K · filed 2025-10-08 | |||
| 2023-12-31 | 1.29M shares 6-K · filed 2025-10-08 | |||
| 2023-06-30 | 775.34K shares 6-K · filed 2024-12-20 | |||
| 2022-12-31 | 54.05K shares 6-K · filed 2025-10-08 |